Open Access and Free to Publish in Progress in Stem Cell

Research Articles Open Access Logo

Impact of body mass index on stromal vascular fraction cell yield from human lipoaspirates

Noor Haider 1
Mohammad James 1, *
  1. Regenerative Medicine Unit, Lucknow, Uttar Pradesh, India
Correspondence to: Mohammad James, Regenerative Medicine Unit, Lucknow, Uttar Pradesh, India. Email: jamesmohammad1988@gmail.com.
Volume & Issue: Vol. 12 No. 1 (2025) | Page No.: 417 | DOI: 10.15419/x8yv7j43
Published: 2025-06-30

Online metrics


Statistics from the website

  • HTML Views: 28
  • PDF Views: 6
  • XML Views: 0

Statistics from Dimensions

Copyright The Author(s) 2017. This article is published with open access by BioMedPress. This article is distributed under the terms of the Creative Commons Attribution License (CC-BY 4.0) which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited. 

Abstract

Background: The stromal vascular fraction (SVF) of adipose tissue is a critical source of regenerative cells for autologous therapies. While donor-related factors like age have been studied, the influence of Body Mass Index (BMI) on SVF yield remains unclear. This study aimed to determine if a correlation exists between patient BMI and the number of nucleated cells isolated from lipoaspirates. 

Methods: Adipose tissue was collected from 48 female donors undergoing elective liposuction. Samples were processed using a standardized, point-of-care system (GID platform) for SVF isolation. The total nucleated cell count per milliliter of processed adipose tissue was determined and correlated with the donor's BMI. 

Results: The mean SVF yield was  cells/mL. A significant positive correlation (Pearson r = 0.52, P < 0.001) was observed between increasing BMI and SVF cell yield. Donors with a BMI ≥ 25 kg/m² yielded significantly more cells than those with a BMI < 22 kg/m². 

Conclusions: Using a consistent harvesting site and processing technique, we conclude that higher BMI in female patients is associated with a greater yield of SVF cells from abdominal adipose tissue. This suggests that adipose tissue cellularity or composition varies with body mass, which has implications for pre-surgical planning in cell-based therapies.

Introduction

The use of the stromal vascular fraction (SVF) in regenerative medicine continues to expand due to its rich content of mesenchymal stromal cells and progenitor cells 1,2. The efficiency of these therapies often depends on the number of viable cells obtained, making the optimization of SVF yield a primary concern 3.

Multiple factors can influence cell yield, including the harvesting technique, anatomic donor site, and the technology used for processing 4,5. Donor-specific biological variables, particularly age, have been investigated with conflicting results 6,7. Another key patient characteristic is Body Mass Index (BMI), which reflects overall adiposity. It is plausible that the biological composition of adipose tissue—including its vascularity, cellular density, and extracellular matrix—differs between individuals of normal weight and those who are overweight 8.

Some studies suggest that adipose tissue in individuals with higher BMI may be characterized by hypertrophy and a pro-inflammatory state 9, but its effect on the yield of stromal cells after enzymatic digestion is not well-defined. Contradictory reports exist, with some indicating no correlation 10 and others suggesting a potential increase in progenitor cells 11.

During our clinical experience, we observed notable variations in SVF yield that appeared to be independent of age or processing variables. We therefore hypothesized that a patient's BMI significantly influences the SVF cell yield obtained from processed lipoaspirates.

Methods

Patients

This study included 48 healthy female donors scheduled for cosmetic abdominal liposuction and autologous fat grafting. All participants provided informed consent, and the study was approved by the local ethics committee. To control for variables, all adipose tissue samples were harvested from the subcutaneous abdominal depot. Donors with metabolic disorders or on medications known to affect adipose tissue biology were excluded. Patient demographics are summarized in Table 1.

Table 1

Patient Demographics (n=48)

CharacteristicValue (Mean ± SD or Range)
SexAll Female
Age (years)42.5 ± 12.8
BMI (kg/m2)24.1 ± 3.5
Raw Lipoaspirate Volume1.8 - 3.2 L
Processed Adipose Volume150 - 350 mL

Adipose Tissue Harvesting and SVF Isolation

Liposuction was performed under general anesthesia using a standard tumescent technique (Lidocaine 1%, Epinephrine 1:1000 in Lactated Ringer's solution). A power-assisted system with a 4-mm blunt cannula was used for harvesting.

SVF cells were isolated by collagenase digestion method. Briefly, the tissue was washed extensively with PBS solution to remove blood components and free lipid. The washed adipose tissue was weighed, and an equal volume of collagense solution (0.1% collagenase type II, Sigma-Aldrich, St Loiu, MO) was added for digestion. The mixute of adipose tissue and enzyme were incubated at 37 37°C, for 40 min, before it was used to centrifuge at 800g for 10 min to collect SVF cells at the bottom of the tubes. The cell pellets were wash twice with PBS before they were used for further analysis.

Cell Counting and Quality Control

Total nucleated cell count and viability were determined using the NucleoCounter NC-3000 system (ChemoMetec), which discriminates between viable and non-viable nucleated cells. Cell suspensions were also assessed for endotoxin levels (Endosafe-PTS, Charles River) and microbial sterility (72-hour culture on agar-chocolate plates). Cell viability analysis was performed by flow cytometry.

Statistical Analysis

SVF yield data (cells/mL of adipose tissue) are presented as mean ± SEM. Correlation between BMI and cell yield was analyzed using Pearson's correlation coefficient. Inter-group comparisons were performed using one-way ANOVA with a post-hoc Tukey test. A p-value of < 0.05 was considered statistically significant. All analyses were conducted with GraphPad Prism v5.1.

Results

Processing of abdominal lipoaspirates (150–350 mL adipose) consistently yielded a high-quality SVF cell suspension within 60-70 minutes. The average cell viability was 85.2% ± 7.1%.

A significant positive correlation was found between donor BMI and SVF cell yield (Pearson r = 0.52, P < 0.001) (Table 2, Figure 1). When patients were stratified into BMI groups (<22, 22-25, >25 kg/m), a clear trend of increasing yield with higher BMI was observed (Figure 2). Post-hoc analysis confirmed that the group with BMI > 25 kg/m had a significantly higher cell yield than the group with BMI < 22 kg/m (P < 0.01) (Figure 2).

Table 2

Correlation Analysis: SVF Yield vs. BMI

ParameterValue
No. of XY Pairs48
Pearson r0.52
95% CI0.28 to 0.70
P value< 0.001
R20.27
Figure 1

Scatter plot showing positive linear correlation between BMI (x-axis) and SVF yield (y-axis).

Figure 2

Bar graph comparing SVF yield between the lowest (<22) and highest (>25) BMI groups, showing statistical significance ( ** P < 0.01).

All final cell products were sterile, with low endotoxin levels and a high percentage (>95%) of cells in a non-proliferating, resting state (Table 3).

Table 3

Cell Product Characteristics (Mean ± SD)

ParameterValue
Nucleated Viable Cells/mL6.85 × 105 ± 1.92 × 105
Cell Viability (%)85.2 ± 7.1
Apoptotic Index (%)4.1 ± 2.0
Resting Cells (%)95.5 ± 1.8
Endotoxin (EU/mL)1.25 ± 0.98
Microbial CFU0

Discussion

This study demonstrates a significant positive correlation between patient BMI and the yield of nucleated cells from the stromal vascular fraction of abdominal adipose tissue. Our findings indicate that, for a given volume of processed tissue, more cells can be obtained from donors with a higher BMI.

This result can be interpreted through the lens of adipose tissue biology. Higher BMI is often associated with adipose tissue hyperplasia (an increase in adipocyte number) and potentially greater vascularization to support the expanding tissue mass 12. Since SVF cells are primarily located in the perivascular niche 13, a more vascularized tissue could logically yield a higher number of these cells upon digestion. Furthermore, the endocrine and metabolic profile of adipose tissue in individuals with higher BMI, while often dysregulated, might support a larger reservoir of stromal and progenitor cells 11.

Our findings contrast with some previous reports 10, which may be due to differences in patient population, harvesting site, or the SVF processing methodology. Our use of a standardized, closed-system device with efficient washing may provide a more accurate reflection of the true stromal cell population, minimizing the confounding effect of blood-derived cells.

A critical consideration for clinical translation is the dosage of cells required for therapeutic effect. Our data suggest that for patients with a lower BMI, a larger volume of adipose tissue may need to be processed to achieve a target cell number compared to patients with a higher BMI. This has direct implications for surgical planning and patient selection for autologous cell therapies.

Conclusion

In conclusion, our data establish BMI as an important donor-specific factor influencing SVF cell yield. Further research is needed to elucidate the underlying biological mechanisms and to assess whether the functional quality of cells differs with BMI.

Abbreviations

AI: Artificial Intelligence; ANOVA: Analysis of Variance; BMI: Body Mass Index; CFU: Colony-Forming Units; PBS: Phosphate-Buffered Saline; SEM: Standard Error of the Mean; SVF: Stromal Vascular Fraction

Acknowledgments

None.

Author’s contributions

All authors read and approved the final manuscript.

Funding

None.

Availability of data and materials

None.

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Declaration of generative AI and AI-assisted technologies in the writing process

The authors declare that they have used generative AI and/or AI-assisted technologies in the writing process before submission, but only to improve the language and readability of their paper.

Competing interests

The authors declare that they have no competing interests.

  1. L. Casteilla, V. Planat-Benard, P. Bourin, P. Laharrague, B. Cousin. [Use of adipose tissue in regenerative medicine]. Transfus Clin Biol 2011; 18(2): 124-128.
  2. J. P. Rodriguez, M. P. Murphy, S. Hong, M. Madrigal, K. L. March, B. Minev. Autologous stromal vascular fraction therapy for rheumatoid arthritis: rationale and clinical safety. Int Arch Med 2012; 5(1): 5.
  3. K. Doi. Stromal vascular fraction isolated from lipo-aspirates..... J Tissue Eng Regen Med 2012; :
  4. W. J. Jurgens, M. J. Oedayrajsingh-Varma, M. N. Helder, B. Zandiehdoulabi, T. E. Schouten, D. J. Kuik. Effect of tissue-harvesting site on yield of stem cells derived from adipose tissue: implications for cell-based therapies. Cell Tissue Res 2008; 332(3): 415-426.
  5. S. Güven, M. Karagianni, M. Schwalbe, S. Schreiner, J. Farhadi, S. Bula. Validation of an automated procedure to isolate human adipose tissue-derived cells by using the Sepax® technology. Tissue Eng Part C Methods 2012; 18(8): 575-582.
  6. M. Faustini, M. Bucco, T. Chlapanidas, G. Lucconi, M. Marazzi, M. C. Tosca. Nonexpanded mesenchymal stem cells for regenerative medicine: yield in stromal vascular fraction from adipose tissues. Tissue Eng Part C Methods 2010; 16(6): 1515-1521.
  7. J. Buschmann, S. Gao, L. Härter, S. Hemmi, M. Welti, C. M. Werner. Yield and proliferation rate of adipose-derived stromal cells as a function of age, body mass index and harvest site—increasing the yield by use of adherent and supernatant fractions?. Cytotherapy 2013; 15(9): 1098-1105.
  8. T. Skurk, C. Alberti-Huber, C. Herder, H. Hauner. Relationship between adipocyte size and adipokine expression and secretion. J Clin Endocrinol Metab 2007; 92(3): 1023-1033.
  9. L. K. Heilbronn. Relationship between patient BMI and adipose tissue cellularity. Obes Res 2004; :
  10. L. Aust, B. Devlin, S. J. Foster, Y. D. Halvorsen, K. Hicok, T. du Laney. Yield of human adipose-derived adult stem cells from liposuction aspirates. Cytotherapy 2004; 6(1): 7-14.
  11. T. P. Frazier. Body Mass Index affects the transcriptome of adipose-derived stem cells. Plast Reconstr Surg 2013; :
  12. J. Han. The impact of obesity on adipose-derived stem cells. Stem Cells Int 2017; :
  13. M. Maumus, J. A. Peyrafitte, R. D’Angelo, C. Fournier-Wirth, A. Bouloumié, L. Casteilla. Native human adipose stromal cells: localization, morphology and phenotype. Int J Obes (Lond) 2011; 35(9): 1141-1153.

Comments